NAFDAC Registration & Regulatory Affairs (R & R) Directorate Guideline on Registration Requirements to Establish Interchangeability of Generic Pharmaceutical Products
Ministry of Health, National Agency for food and Drug Administration and Control
This document is an adaptation of the World Health Organization (WHO) guidelines on registration requirements to establish interchangeability. It provides appropriate In vivo and In vitro requirements to assure interchangeability of the generic product without compromising the safety, quality and efficacy of the pharmaceutical product and is generally applicable to orally administered generic products as well as to certain non-orally administered pharmaceutical products (e.g. transdermal delivery systems and certain parenteral, rectal and nasal pharmaceutical products.